Sorry I was wrong it was a $218k bonus, but he also got $931000 in options, + salary of $633,627 = a grand total of $1,729,560 for calendar year 2024.
These were the KPIs he met (taken from annual report).
"Dr Monil Shah received a $218,120 performance bonus for FY24. The bonus was for meeting performance milestones
(KPI in relation to onCARlytic partnering, developing business development strategies for the Company and securing
clinical supply agreements). Amounts paid to Dr Monil Shah are paid in US dollars but disclosed in Australian dollars."
Ann: Imugene Webinar - Azer-cel Trial Update, page-74
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.002(4.35%) |
Mkt cap ! $357.0M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.9¢ | 4.6¢ | $977.7K | 20.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3232340 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 854027 | 4 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |